HealthCare Royalty Announces Closing of Credit Facility, New Debt Focused Fund and Appointment of Josh House as West Coast Lead
The credit facility includes a $380 million term loan and a $300 million revolving credit facility; the revolving credit facility remains undrawn.
- The credit facility includes a $380 million term loan and a $300 million revolving credit facility; the revolving credit facility remains undrawn.
- With the closing of this financing, the Company has over $1 billion of liquidity.
- HCRx Holdings will use its capital to expand its leading presence in the biopharmaceutical royalty acquisition space during a time of unprecedented market opportunity.
- “Josh brings a differentiated view to our investment process with 10 years of healthcare experience covering operational and investment banking roles.